R. Adam Smith

749 total citations
19 papers, 441 citations indexed

About

R. Adam Smith is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, R. Adam Smith has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in R. Adam Smith's work include Cancer Immunotherapy and Biomarkers (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Medical Imaging Techniques and Applications (4 papers). R. Adam Smith is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Medical Imaging Techniques and Applications (4 papers). R. Adam Smith collaborates with scholars based in United States, Netherlands and United Kingdom. R. Adam Smith's co-authors include Eliot T. McKinley, Ping Zhao, M. Kay Washington, H. Charles Manning, H. Charles Manning, Robert J. Coffey, Samir Saleh, Allie Fu, Wendy Hayes and Samuel J. Bonacorsi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

R. Adam Smith

18 papers receiving 434 citations

Peers

Countries citing papers authored by R. Adam Smith

Since Specialization

Citations

This map shows the geographic impact of R. Adam Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Adam Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Adam Smith more than expected).

Fields of papers citing papers by R. Adam Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Adam Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Adam Smith. The network helps show where R. Adam Smith may publish in the future.

Co-authorship network of co-authors of R. Adam Smith

This figure shows the co-authorship network connecting the top 25 collaborators of R. Adam Smith. A scholar is included among the top collaborators of R. Adam Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Adam Smith. R. Adam Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic 2021 ·Frontiers in Oncology ·David Leung, Samuel J. Bonacorsi, R. Adam Smith, Wolfgang Weber, Wendy Hayes	14
2	Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA₁) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD) 2021 ·BMJ Open Respiratory Research ·Tamera J. Corte, Lisa Lancaster, Jeffrey J. Swigris, Toby M. Maher, Jonathan Goldin, Scott M. Palmer, Takafumi Suda, Takashi Ogura, Anne Minnich, Xiaojiang Zhan, Giridhar Tirucherai, (unknown), Hong Xiao, Hideaki Watanabe, R. Adam Smith, Edgar D. Charles, Aryeh Fischer	35
3	Whole body PD-L1 PET in patients with NSCLC and melanoma. 2018 ·Journal of Clinical Oncology ·David Leung, J. De Langen, David Raunig, Anna-Larissa N. Niemeijer, Egbert F. Smit, Ronald Boellaard, David Vállez García, Guus A.M.S. van Dongen, Albert D. Windhorst, Marc C. Huisman, Andor W.J.M. Glaudemans, N. Harry Hendrikse, R. Adam Smith, Alex J. Poot, Daša Lipovšek, David J. Donnelly, Samuel J. Bonacorsi, Linda Velasquez, Shuyan Du, Wendy Hayes	2
4	Whole body PD-1 and PD-L1 PET in pts with NSCLC 2017 ·Annals of Oncology ·(unknown), Egbert F. Smit, Idris Bahce, O. S. Hoekstra, (unknown), Guus AMS van Dongen, Albert D. Windhorst, N. Harry Hendrikse, Alex J. Poot, Daniëlle J. Vugts, David Leung, Wendy Hayes, R. Adam Smith, L. Wilson, Erik Thunnissen, J. De Langen	3
5	Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates 2017 ·Bioorganic & Medicinal Chemistry ·Erin L. Cole, Joon‐Young Kim, David J. Donnelly, R. Adam Smith, Daniel N. Cohen, Virginie Lafont, Paul E. Morin, Richard Y.‐C. Huang, Patrick L Chow, Wendy Hayes, Samuel J. Bonacorsi	76
6	Whole body PD-1 and PD-L1 PET with ⁸⁹Zr-nivolumab and ¹⁸F- BMS-986192 in pts with NSCLC. 2017 ·Journal of Clinical Oncology ·Anna-Larissa N. Niemeijer, Egbert F. Smit, Guus A.M.S. van Dongen, Albert D. Windhorst, Marc C. Huisman, N. Harry Hendrikse, David Leung, R. Adam Smith, Wendy Hayes, Linda Velasquez, Samuel J. Bonacorsi, David J. Donnelly, Paul E. Morin, Erik Thunnissen, Alex J. Poot, Daniëlle J. Vugts, J. De Langen	10
7	A comparative assessment of preclinical chemotherapeutic response of tumors using quantitative non-Gaussian diffusion MRI 2016 ·Magnetic Resonance Imaging ·Junzhong Xu, Ke Li, R. Adam Smith, John C. Waterton, Ping Zhao, Zhaohua Ding, Mark D. Does, H. Charles Manning, John C. Gore	6
8	3′-Deoxy-3′-¹⁸F-Fluorothymidine PET Predicts Response to ^V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer 2013 ·Journal of Nuclear Medicine ·Eliot T. McKinley, R. Adam Smith, Ping Zhao, Allie Fu, Samir Saleh, Md. Imam Uddin, M. Kay Washington, Robert J. Coffey, H. Charles Manning	23
9	Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology 2013 ·PLoS ONE ·Eliot T. McKinley, Gregory D. Ayers, R. Adam Smith, Samir Saleh, Ping Zhao, M. Kay Washington, Robert J. Coffey, H. Charles Manning	81
10	Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide 2012 ·Journal of Nuclear Medicine ·Dewei Tang, Matthew R. Hight, Eliot T. McKinley, Allie Fu, Jason R. Buck, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, M. Sib Ansari, Michael L. Nickels, H. Charles Manning	55
11	Characterizing Tumor Response to Chemotherapy at Various Length Scales Using Temporal Diffusion Spectroscopy 2012 ·PLoS ONE ·Junzhong Xu, (unknown), R. Adam Smith, John C. Waterton, Ping Zhao, Heidi Chen, Mark D. Does, H. Charles Manning, John C. Gore	46
12	[18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier’s disease 2012 ·Annals of Nuclear Medicine ·Eliot T. McKinley, R. Adam Smith, Jarred Tanksley, M. Kay Washington, Ronald C. Walker, Robert J. Coffey, H. Charles Manning	11
13	Abstract 4529: Prognostic implications of TSPO in human colorectal cancer 2012 ·Cancer Research ·Eliot T. McKinley, Gregory D. Ayers, R. Adam Smith, Ping Zhao, M. Kay Washington, (unknown)	0
14	Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using ¹⁸F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline 2010 ·Journal of Nuclear Medicine ·Jason R. Buck, Eliot T. McKinley, Matthew R. Hight, Allie Fu, Dewei Tang, R. Adam Smith, Mohammed Noor Tantawy, Todd E. Peterson, Daniel C. Colvin, (unknown), Ronald M. Baldwin, Ping Zhao, (unknown), H. Charles Manning	51
15	Abrogation of antibody‐induced arthritis in mice by a self‐activating viridin prodrug and association with impaired neutrophil and endothelial cell function 2009 ·Arthritis & Rheumatism ·Lars Stangenberg, Chris D. Ellson, Virna Cortez‐Retamozo, Adriana Ortiz-Lopez, Hushan Yuan, (unknown), R. Adam Smith, Michael B. Yaffe, Ralph Weissleder, Christophe Benoıst, Diane Mathis, Lee Josephson, Umar Mahmood	1
16	A Wortmannin−Cetuximab as a Double Drug 2009 ·Bioconjugate Chemistry ·R. Adam Smith, Hushan Yuan, Ralph Weissleder, Lewis C. Cantley, Lee Josephson	7
17	Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage 2008 ·International Journal of Nanomedicine ·R. Adam Smith	10
18	Borderlander: The Life of James Kirker, 1793-1852 2001 ·Journal of American History ·Roger L. Nichols, R. Adam Smith	3
19	Indians in American-Mexican Relations Before the War of 1846 1963 ·Hispanic American Historical Review ·R. Adam Smith	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact